- Home
- BUSE vs SLNO Comparison
BUSE vs SLNO Comparison
Compare BUSE & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BUSE | SLNO |
|---|---|---|
| Founded | 1868 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BUSE | SLNO |
|---|---|---|
| Price | $26.93 | $52.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | $27.00 | ★ $83.00 |
| AVG Volume (30 Days) | 515.5K | ★ 6.4M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.85% | N/A |
| EPS Growth | N/A | ★ 108.90 |
| EPS | ★ 1.47 | 0.39 |
| Revenue | ★ $719,584,000.00 | $1,450,788.00 |
| Revenue This Year | $23.84 | $150.46 |
| Revenue Next Year | $3.82 | $50.37 |
| P/E Ratio | ★ $18.34 | $135.31 |
| Revenue Growth | 55.66 | ★ 138.82 |
| 52 Week Low | $19.91 | $29.43 |
| 52 Week High | $27.65 | $89.12 |
Technical Indicators
Market Signals| Indicator | BUSE | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 62.23 | 77.16 |
| Support Level | $23.39 | $48.91 |
| Resistance Level | $27.09 | $55.47 |
| Average True Range (ATR) | 0.48 | 1.00 |
| MACD | 0.10 | 0.88 |
| Stochastic Oscillator | 85.71 | 99.47 |
Price Performance
Historical ComparisonAbout BUSE First Busey Corporation
First Busey Corporation is a financial holding company whose subsidiaries provide retail and commercial banking services, remittance processing, and offer financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech, and Wealth Management. The banking segment generates a vast majority of its revenue.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.